Effects of Some Olive Fruits-Derived Products on Oxidative Stress and Cardiovascular Biomarkers on Experimental Diabetes Mellitus
Authors:
- José Pedro De La CruzJCJosé Pedro De La Cruz
- Laura Iserte-TerrerLILaura Iserte-Terrer
- María Dolores Rodríguez-PérezMRMaría Dolores Rodríguez-Pérez
- Laura Ortega-HombradosLOLaura Ortega-Hombrados
- Ana María Sánchez-TévarASAna María Sánchez-Tévar
- María Monsalud Arrebola-RamírezMAMaría Monsalud Arrebola-Ramírez
- María África Fernández-PriorMFMaría África Fernández-Prior
- Cristina Verdugo-CabelloCVCristina Verdugo-Cabello
- Juan Antonio Espejo-CalvoJEJuan Antonio Espejo-Calvo
- José Antonio González-CorreaJGJosé Antonio González-Correa
Open Access
- 18 September 2024
- journal article
- research article
- Published by MDPI AG in Antioxidants
- Vol. 13 (9) , 1127
Abstract
The aim of this study is to assess the possible effect of olive seed oil (OSO) and destoned and dehydrated olive oil (DDOO), in comparison with extra-virgin olive oil (EVOO), on some cardiovascular biomarkers in an experimental model of diabetes mellitus. Diabetic animals showed evident alterations in biomarkers involved in the evolution of diabetic vasculopathy, marked by increases in biomarkers that favor vascular damage, which was between 1.5 and five times as many as those in non-diabetic animals, and a smaller number of biomarkers that protect against such damage (25–75% less than in healthy controls) was observed. The three oils administered decreased the concentration of biomarkers of vascular damage (35–45% in the serum lipid profile, 15–40% in early biomarkers of vascular inflammation and 20–60% in platelet aggregation and in thromboxane/prostacyclin imbalance). The greatest effect was by the antioxidant, both in the inhibition of lipid peroxidation and in the increase of glutathione. DDOO showed a significantly greater effect on oxidative stress and on thromboxane/prostacyclin imbalance than those shown by OSO and EVOO. This greater effect may possibly be explained by its higher triterpenoid content (913 mg/kg, compared to 113 mg/kg in OSO and 75 mg/kg in EVOO). We conclude, in the light of the results of this study, that these oils meet two basic conditions: they could improve the yield of the olive industry, and they equal, and may even increase, the beneficial effects of EVOO on cardiovascular disease.Keywords
Funding Information
- Ministry of Economy, Industry and Competitiveness of Spain (ITC-20161265, UMA-20-FEDERJA-54)
This publication has 38 references indexed in Scilit:
- Olive oil industry: a review of waste stream composition, environmental impacts, and energy valorization pathsEnvironmental Science and Pollution Research, 2023
- Streptozotocin‐Induced Diabetic Models in Mice and RatsCurrent Protocols, 2021
- Plantain (Plantago L.) species as modulators of prostaglandin E2 and thromboxane A2 production in inflammationJournal of Ethnopharmacology, 2020
- The Mediterranean diet decreases prothrombotic microvesicle release in asymptomatic individuals at high cardiovascular riskClinical Nutrition, 2020
- Novel factor Xa inhibitor, maslinic acid, with antiplatelet aggregation activityJournal of Cellular Physiology, 2020
- De-stoning technology for improving olive oil nutritional and sensory features: The right idea at the wrong timeFood Research International, 2018
- Inhibitory and synergistic effects of natural olive phenols on human platelet aggregation and lipid peroxidation of microsomes from vitamin E-deficient ratsEuropean Journal of Nutrition, 2014
- Maslinic acid protects vascular smooth muscle cells from oxidative stress through Akt/Nrf2/HO-1 pathwayMolecular and Cellular Biochemistry, 2014
- Extra virgin olive oil (EVOO) consumption and antioxidant status in healthy institutionalized elderly humansArchives of Gerontology and Geriatrics, 2013
- Dietary Virgin Olive Oil Reduces Oxidative Stress and Cellular Damage in Rat Brain Slices Subjected to Hypoxia–ReoxygenationLipids, 2007